Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (231-240 of 429) with videos related to

Pageof 43
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.
Cancer|August 30, 2022
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variantsYing L Liu, Anna Maio, Yelena Kemel, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
Gynecologic Oncology|December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survivalRyan M Kahn, Pier Selenica, Thomas Boerner, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Breast Cancer Research and Treatment|January 4, 2012
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersYael Laitman, Karoline B Kuchenbaecker, Johanna Rantala, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Gynecologic Oncology|May 7, 2023
Germline drivers of gynecologic carcinosarcomasTiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Pageof 43

Showing results (231-240 of 429) with videos related to

Sort By:
Pageof 43
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.
Cancer|August 30, 2022
Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variantsYing L Liu, Anna Maio, Yelena Kemel, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
Gynecologic Oncology|December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survivalRyan M Kahn, Pier Selenica, Thomas Boerner, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Breast Cancer Research and Treatment|January 4, 2012
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersYael Laitman, Karoline B Kuchenbaecker, Johanna Rantala, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort studyKelly M Morgan, Jada G Hamilton, Heather Symecko, et al.
Gynecologic Oncology|May 7, 2023
Germline drivers of gynecologic carcinosarcomasTiffany Y Sia, Sushmita B Gordhandas, Ozge Birsoy, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.
Pageof 43